The current analyst and expert consensus on Seattle Genetics is Hold with 6 hold recommendations. The current projected target price consensus is 57.73 with 11 analysts opinions. One of the most common ways Seattle Genetics Inc analysists use to provide buy or sell recommendation to public are conference calls analysis and financial statements evaluations. Some experts can also talk to Seattle Genetics vendors, executives, and/or customers. Seattle Genetics recommendation module provides expert sentiment on the projected Seattle Genetics Inc target price to derive its highest and lowest estimates based on target price standard deviation of 10.04. Also please take a look at Macroaxis Advice on Seattle Genetics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.